羊种布鲁氏菌16MΔwzm的疫苗特性及妊娠绵羊胎盘感染再激活
研究羊种布鲁氏菌16MΔwzm缺失株在妊娠小鼠和绵羊中的安全性及免疫原性。小鼠中该株可预防胎盘和胎儿感染并抵抗羊种布鲁氏菌和绵羊布鲁氏菌感染。绵羊中该株对羔羊、公羊和未孕母羊安全,但妊娠中期接种后部分母羊分娩时胎盘和/或乳汁出现短暂感染再激活,故应避免妊娠中期使用。
要点
- 16MΔwzm在小鼠中可预防胎盘和胎儿感染,并抵抗羊种和绵羊布鲁氏菌感染。
- 在羔羊、公羊和未孕母羊中16MΔwzm安全,仅引起短暂玫瑰红试验反应(<7周)。
- 妊娠中期接种后部分母羊分娩时胎盘和/或乳汁出现短暂感染再激活,应避免妊娠中期使用。
核心结论
- 16MΔwzm可被视为对羔羊、公羊和未孕母羊安全的疫苗,但应避免在妊娠中期使用以防止分娩时疫苗散播。
- 若小鼠中对羊种布鲁氏菌和绵羊布鲁氏菌的效力结果在自然宿主中经进一步研究证实,16MΔwzm可成为有用疫苗。
研究设计与样本
- 研究羊种布鲁氏菌16MΔwzm框内缺失突变株的生物学特性,包括在妊娠小鼠和绵羊中的安全性。
主要发现
- 在小鼠中,16MΔwzm在分娩前预防胎盘和胎儿感染,并抵抗羊种布鲁氏菌和绵羊布鲁氏菌感染。
- 在绵羊中,16MΔwzm对羔羊、公羊和未孕母羊同样安全,引起一些短暂玫瑰红试验反应(<7周)。
- 妊娠母羊的血清学反应出现更早且更强,结膜接种较皮下接种显著降低血清学反应。
- 妊娠中期接种的母羊中,16MΔwzm未在孕期阴道分泌物中排出,未引起流产/死胎;但部分母羊分娩时胎盘和/或乳汁出现短暂感染再激活,伴平滑LPS和/或粗糙LPS试验血清学转换。
临床怎么用
- 作者认为16MΔwzm对羔羊、公羊和未孕母羊是安全疫苗,但应避免在妊娠中期使用以防止分娩时疫苗散播。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Brucellosis, a worldwide zoonotic disease, is endemic in many developing countries. Besides causing significant economic losses for the livestock industry, it has severe consequences for human health. In endemic regions, small ruminants infected by Brucella melitensis are the main source of human brucellosis. Rev1, the only vaccine currently recommended to control the disease in sheep and goats, has several drawbacks. Rough lipopolysaccharide (R-LPS) mutants have been tested as alternatives, but most lack efficacy. Those in the Wzm/Wzt system responsible for O-polysaccharide export to the periplasm have been proposed as promising vaccine candidates, although to date they have been scarcely investigated in the natural host. In the present work, we studied the biological properties of a 16MΔwzm in-frame deletion mutant, including its safety in pregnant mice and sheep. In mice, 16MΔwzm prevented placental and fetal infections before parturition and protected against B. melitensis and Brucella ovis infections. In sheep, 16MΔwzm was equally safe in lambs, rams, and non-pregnant ewes, inducing some transient Rose Bengal reactions (<7 weeks). The serological reactions occurred earlier and more strongly in pregnant than in non-pregnant ewes and were significantly reduced when conjunctival rather than subcutaneous vaccination was used. In ewes vaccinated at mid-pregnancy, 16MΔwzm was not shed in vaginal discharges during the pregnancy and did not induce abortions/stillbirths. However, some ewes showed a transitory reactivation of infection in placentas and/or milk at parturition, accompanied by a seroconversion in smooth LPS (S-LPS) and/or R-LPS tests. Overall, 16MΔwzm can be considered as a safe vaccine for lambs, rams, and non-pregnant ewes, but its use at mid-pregnancy should be avoided to prevent vaccine dissemination at parturition. If the efficacy results against B. melitensis and B. ovis observed in mice are confirmed by further studies in the natural host, 16MΔwzm could constitute a useful vaccine.
引用
- Zabalza-Baranguá A, Poveda-Urkixo I, Mena-Bueno S, et al. Vaccine properties of Brucella melitensis 16MΔwzm and reactivation of placental infection in pregnant sheep. Vaccine. 2023. PMID: 36653223. doi:10.1016/j.vaccine.2023.01.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。